Krensavage Asset Management, LLC has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $178 Million distributed in 13 stocks.

Among their holdings, we can observe that their the top five positions include companies like: United Therapeutics Corp with a value of $36M, Exelixis, Inc. with a value of $33.3M, Cardinal Health Inc with a value of $23.2M, Biogen Inc. with a value of $22M, and Enanta Pharmaceuticals Inc with a value of $15.5M.

Examining the 13F form we can see an decrease of $39.3M in the current position value, from $218M to 178M.

Krensavage Asset Management, LLC is based out at New York, NY

Below you can find more details about Krensavage Asset Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $178 Million
Healthcare: $171 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 13
  • Current Value $178 Million
  • Prior Value $218 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 1 stocks
  • Additional Purchases 3 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 9 stocks
Track This Portfolio

Track Krensavage Asset Management, LLC Portfolio

Follow Krensavage Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Krensavage Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Krensavage Asset Management, LLC with notifications on news.